Brief: Erytech Provides Business Update And Reports Financial Results For The First Quarter Of 2021

Phaxiam Therapeutics SA

04/05/2021 21:57

May 4 (Reuters) - Erytech Pharma SA  ERYP.PA :
    * ERYTECH PROVIDES BUSINESS UPDATE AND  REPORTS FINANCIAL
RESULTS
FOR THE FIRST QUARTER OF 2021
    * ERYTECH PHARMA SA - CASH HORIZON EXTENDED TO MID 2022,
BEYOND
ANTICIPATED KEY CATALYSTS
    * ERYTECH PHARMA SA - BELIEVES WOULD BE ABLE TO FUND
OPERATIONS
INTO Q3 OF 2022 IF IT UTILIZES OCABSA AGREEMENT, SUBJECT TO
REGULATORY LIMIT OF 20% DILUTION
    * ERYTECH PHARMA SA - NET LOSS FOR Q1 OF 2021 WAS EUR 11.9
MILLION, DOWN EUR 5.6 MILLION

Source text for Eikon:  ID:nGNXyxP3D 
Further company coverage:  ERYP.PA 

 ((Reuters.Briefs@thomsonreuters.com;))